The emerging role of infectious pathogens in neurodegenerative diseases

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 553-555

  Langford, Dianne ^a   Masliah, Eliezer ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; BACTERIAL RNA; RIBOSOME RNA;

ALZHEIMER DISEASE; BORRELIA BURGDORFERI; BRAIN INFECTION; CHLAMYDOPHILA PNEUMONIAE; CRYPTOCOCCUS NEOFORMANS; DEGENERATIVE DISEASE; DEMENTIA; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MEASLES VIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NERVE DEGENERATION; NOCARDIA ASTEROIDES; NONHUMAN; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SPIROCHETE; TREPONEMA;

EID: 0842320918     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00365-0     Document Type: Note

References (41)

1. Balin B.J., Gerard H.C., Arking E.J., Appelt D.M., Branigan P.J., Abrams J.T., Whittum-Hudson J.A., Hudson A.P. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl.). 187:1998;23-42.
2. Beaman B.L. Bacteria and neurodegeneration. Caino D. Neurodegenerative Diseases. 1994;319-338 W.B. Saunders, Orlando, FL.
3. Broxmeyer L. Parkinson's: another look. Med. Hypotheses. 59:2002;373-377.
4. Conway K., Harper J., Lansbury P. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4:1998;1318-1320.
5. Chapman G., Beaman B.L., Loeffler D.A., Camp D.M., Domino E.F., Dickson D.W., Ellis W.G., Chen I., Bachus S.E., LeWitt P.A. In situ hybridization for detection of nocardial 16S rRNA: reactivity within intracellular inclusions in experimentally infected cynomolgus monkeys - and in Lewy body-containing human brain specimens. Exp. Neurol. 184:2003;715-725.
6. DeArmond S.J., Bouzamondo E. Fundamentals of prion biology and diseases. Toxicology. 181-182:2002;9-16.
7. Deykin E.Y., MacMahon B. Viral exposure and autism. Am. J. Epidemiol. 109:1979;628-638.
8. El-Agnaf O., Jakes R., Curran M., Wallace A. Effects of the mutations Ala30 to Pro and Ala 53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. FEBS Lett. 440:1998;67-70.
9. Feany M., Bender W. A Drosophila model of Parkinson's disease. Nature. 404:2000;394-398.
10. Gieffers J., Reusche E., Solbach W., Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J. Clin. Microbiol. 38:2000;881-882.
11. Golbe L. Alpha-synuclein and Parkinson's disease. Mov. Disord. 14:1999;6-9.
12. Gutacker M., Valsangiacomo C., Balmelli T., Bernasconi M.V., Bouras C., Piffaretti J.C. Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Res. Microbiol. 149:1998;31-37.
13. Hashimoto M., Masliah E. Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol. 9:1999;707-720.
14. Hashimoto M., Hernandez-Ruiz S., Hsu L., Sisk A., Xia Y., Takeda A., Sundsmo M., Masliah E. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799:1998;301-306.
15. Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., Masliah E. Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277:2002;11465-11472.
16. Hurtig H., Trojanowski J., Galvin J., Ewbank D., Schmidt M., Clark C., Glosser G., Stern M., Gollomp S., Arnold S. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 54:2000;1916-1921.
17. Jenner P., Dexter D., Sian J., Schapira A., Mardsen C. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinsons's Disease Research Group. Ann. Neurol. 32:1992;S82-S87.
18. Kohbata S., Beaman B.L. L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice. Infect. Immun. 59:1991;181-191.
19. Kotzbauer P.T., Trojanowsk J.Q., Lee V.M. Lewy body pathology in Alzheimer's disease. J. Mol. Neurosci. 17:2001;225-232.
20. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J., Schols L., Reiss O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinsons's disease. Nat. Genet. 18:1998;106-108.
21. Kurosinski P., Guggisberg M., Gotz J. Alzheimer's and Parkinson's disease - Overlapping or synergistic pathologies? Trends Mol. Med. 8:2002;3-5.
22. Langenberg A.G., Corey L., Ashley R.L., Leong W.P., Straus S.E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N. Engl. J. Med. 341:1999;1432-1438.
23. Lansbury P.T.J. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. PNAS. 96:1999;3342-3344.
24. Lotharius J., Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3:2002;932-942.
25. MacDonald A.B., Miranda J.M. Concurrent neocortical borreliosis and Alzheimer's disease. Hum. Pathol. 18:1987;759-761.
26. MacIntyre A., Abramov R., Hammond C.J., Hudson A.P., Arking E.J., Little C.S., Appelt D.M., Balin B.J. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J. Neurosci. Res. 71:2003;740-750.
27. Marques A.R., Weir S.C., Fahle G.A., Fischer S.H. Lack of evidence of Borrelia involvement in Alzheimer's disease. J. Infect. Dis. 182:2000;1006-1007.
28. Marttila R.J., Arstila P., Nikoskelainen J., Halonen P.E., Rinne U.K. Viral antibodies in the sera from patients with Parkinson disease. Eur. Neurol. 15:1977;25-33.
29. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 287:2000;1265-1269.
30. McKeith I., Galasko D., Kosaka K., Perry E., Dickson D., Hansen L., Salmon D., Lowe J., Mirra S., Byrne E., Quinn N., Edwardson J., Ince P., Bergeron C., Burns A., Miller B., Lovestone S., Collerton D., Jansen E., de Vos R., Wilcock G., Jellinger K., Perry R. Clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the CDLB International Workshop. Neurology. 47:1996;1113-1124.
31. Miklossy J. Alzheimer's disease - A spirochetosis? NeuroReport. 4:1993;841-848.
32. Polymeropoulos M., Lavedan C., Leroy E., Ide S., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E., Chandrasekharappa S., Athanassiadou A., Papapetropulos T., Johnson W., Lazzarini A., Duvoisin R., Di Iorio G., Golbe L., Nussbaum R. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
33. Prusiner S., Scott M. Genetics of prions. Annu. Rev. Genet. 31:1997;139-175.
34. Pyles R.B. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors. Herpes. 8:2001;64-68.
35. Ring R.H., Lyons J.M. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain. J. Clin. Microbiol. 38:2000;2591-2594.
36. Riviere G.R., Riviere K.H., Smith K.S. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol. Immunol. 17:2002;113-118.
37. Steere A.C. Lyme disease. N. Engl. J. Med. 321:1989;586-596.
38. Trojanowski J., Goedert M., Iwatsubo T., Lee V. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and lewy body dementia. Cell Death Differ. 5:1998;832-837.
39. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Otero D., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 90:1993;11282-11286.
40. Wakabayashi K., Yoshioto M., Tsuji S., Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249:1998;180-182.
41. Yucesan C., Sriram S. Chlamydia pneumoniae infection of the central nervous system. Curr. Opin. Neurol. 14:2001;355-359.